Novo Nordisk A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public
- Established
- 1923-01-01
- Employees
- 63.3K
- Market Cap
- $602.2B
- Website
- http://www.novonordisk.com
A Research Study Looking at New Protein-based Tablets in Healthy Men - Oral Formulation IV
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 90
- Registration Number
- NCT06642584
- Locations
- 🇨🇦
Altasciences, Montreal, Quebec, Canada
A Research Study to Compare How Much of the Medicine NNC0519-0130 is in the Blood of People With Overweight or Obesity Who Receive 2 Preparations of the Medicine
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 46
- Registration Number
- NCT06642571
- Locations
- 🇺🇸
ICON, San Antonio, Texas, United States
A Research Study on the Effects of NNC0537-1482 in Healthy Individuals When Injected Under the Skin
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 56
- Registration Number
- NCT06625307
- Locations
- 🇳🇱
ICON - location Groningen, Groningen, Netherlands
A Research Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- First Posted Date
- 2024-09-25
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 408
- Registration Number
- NCT06612268
- Locations
- 🇺🇸
Stanford University_Palo Alto, Palo Alto, California, United States
🇺🇸Henry Ford Hospital_Detroit, Detroit, Michigan, United States
🇨🇦UHN-Toronto General Hospital, Toronto, Ontario, Canada
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Phase 3
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-24
- Last Posted Date
- 2024-10-09
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 325
- Registration Number
- NCT06609226
- Locations
- 🇺🇸
Univ Miami-Miller School Med, Miami, Florida, United States
🇺🇸Neuro-Behavioral Clinical Research, North Canton, Ohio, United States
🇨🇦Providence Hematolgy, Vancouver, British Columbia, Canada
A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 1500
- Registration Number
- NCT06589791
- Locations
- 🇨🇳
Novo Nordisk Shanghai Pharmaceuticals Co., Ltd, Shanghai, China
Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 38
- Registration Number
- NCT06588504
- Locations
- 🇯🇵
Hakata Clinic, Fukuoka, Japan
Patient Preference Study in Type-2 Diabetes Mellitus: Discrete Choice Experiment (DCE) to Support Novo Nordisk's Long-Acting Insulin
- First Posted Date
- 2024-09-12
- Last Posted Date
- 2024-09-12
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 513
- Registration Number
- NCT06592950
- Locations
- 🇩🇰
Novo Nordisk, Søborg, Denmark
A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 24
- Registration Number
- NCT06581627
- Locations
- 🇨🇳
Beijing Hospital, Beijing, Beijing, China
A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-08-29
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 88
- Registration Number
- NCT06577766
- Locations
- 🇺🇸
ICON, San Antonio, Texas, United States
© Copyright 2024. All Rights Reserved by MedPath